[CAPR] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[CAPR] Capricor Therapeutics, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 9.18%
YoY- -59.31%
Quarter Report
CAPR's Result
CAPR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 2,261,642 6,186 1,592 0 17 142 219 366.00%
PBT -12,556,728 -6,391 -6,371 -3,932 -3,910 -1,607 -4,136 280.06%
Tax -12,556,728 -276 -107 -80 -40 -64 0 -
NP -12,556,728 -6,391 -6,264 -3,932 -3,910 -1,607 -4,136 280.06%
Tax Rate - - - - - - - -
Total Cost 14,818,370 12,576 7,856 3,932 3,927 1,749 4,355 287.34%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -555.20 -103.31 -393.60 0.00 -23,187.59 -1,130.84 -1,886.52 -18.42%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -379.47 -0.25 -0.26 -0.17 -0.20 -0.43 -1.35 155.72%
EPS Diluted -379.47 -0.25 -0.26 -0.17 -0.20 -0.43 -1.35 155.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.